Angiocrine Bioscience

San Diego, CA · Founded 2012 · Privately Held (backing)

Developer of a curative cellular therapies platform designed to treat indications in regenerative medicine and hematopoietic stem cell gene therapy. Angiocrine Bioscience is based in San Diego, CA and was founded in 2012. It was valued at $25.1 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $88.8 million across 2 recorded rounds; the latest was a $2.1 million seed round in Aug 2025.

PMV mark · valuation
$25.1M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$88.8M
Last round
Seed Round
Aug 2025

Who backs Angiocrine Bioscience?

7 investors
InvestorType
Good Growth CapitalVenture capital
Dubin & Co.PE / buyout
Axil Capital Partners—
California Institute for Regenerative Medicine—
Cobro Ventures—
Cornell University—
Gutbrain Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Angiocrine Bioscience investors

7 investors are on record for Angiocrine Bioscience, including Good Growth Capital, Dubin & Co., Axil Capital Partners and California Institute for Regenerative Medicine. The seed round in Aug 2025 drew 16 investors.

Free account
More of Angiocrine Bioscience with a free account
  • ·Watch Angiocrine Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Angiocrine Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View